BBVA USA Bancshares’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,592
| Closed | -$362K | – | 516 |
|
|
2019
Q4 | $362K | Sell |
9,592
-2,927
| -23% | -$110K | 0.02% | 418 |
|
|
2019
Q3 | $584K | Buy |
12,519
+2,394
| +24% | +$112K | 0.04% | 285 |
|
|
2019
Q2 | $530K | Buy |
10,125
+4,062
| +67% | +$213K | 0.03% | 358 |
|
|
2019
Q1 | $418K | Sell |
6,063
-79
| -1% | -$5.45K | 0.03% | 386 |
|
|
2018
Q4 | $366K | Sell |
6,142
-5,382
| -47% | -$321K | 0.03% | 386 |
|
|
2018
Q3 | $1.34M | Buy |
11,524
+897
| +8% | +$104K | 0.08% | 223 |
|
|
2018
Q2 | $1.34M | Buy |
10,627
+1,051
| +11% | +$133K | 0.08% | 213 |
|
|
2018
Q1 | $1.04M | Buy |
9,576
+1,186
| +14% | +$128K | 0.07% | 253 |
|
|
2017
Q4 | $919K | Sell |
8,390
-1,793
| -18% | -$196K | 0.06% | 280 |
|
|
2017
Q3 | $1.01M | Sell |
10,183
-368
| -3% | -$36.3K | 0.07% | 263 |
|
|
2017
Q2 | $1.07M | Buy |
10,551
+780
| +8% | +$79K | 0.07% | 251 |
|
|
2017
Q1 | $1.13M | Buy |
9,771
+2,443
| +33% | +$282K | 0.08% | 239 |
|
|
2016
Q4 | $880K | Buy |
7,328
+899
| +14% | +$108K | 0.06% | 275 |
|
|
2016
Q3 | $722K | Buy |
6,429
+582
| +10% | +$65.4K | 0.05% | 293 |
|
|
2016
Q2 | $725K | Buy |
5,847
+1,409
| +32% | +$175K | 0.05% | 292 |
|
|
2016
Q1 | $498K | Buy |
4,438
+498
| +13% | +$55.9K | 0.04% | 360 |
|
|
2015
Q4 | $429K | Buy |
3,940
+1,422
| +56% | +$155K | 0.03% | 356 |
|
|
2015
Q3 | $251K | Buy |
2,518
+512
| +26% | +$51K | 0.02% | 424 |
|
|
2015
Q2 | $229K | Buy |
+2,006
| New | +$229K | 0.01% | 478 |
|